WLPWM
PPBT

Walled Lake Planning & Wealth Management’s Purple Biotech PPBT Stock Holding History

Walled Lake Planning & Wealth Management’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed – – 263
2021
Q3 		$0 Hold
1
– – ﹤0.01% 339
2021
Q2 		$0 Hold
1
– – ﹤0.01% 316
2021
Q1 		$0 Hold
1
– – ﹤0.01% 362
2020
Q4 		$0 Hold
1
– – ﹤0.01% 344
2020
Q3 		$0 Hold
1
– – ﹤0.01% 359
2020
Q2 		$1K Buy
+1
New +$983 ﹤0.01% 315

Other funds holding PPBT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WTB
Washington Trust Bank Spokane, Washington $1.36B AUM 21.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VVP
Venture Visionary Partners Sylvania, Ohio $3.6B AUM 30.03% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return

Walled Lake Planning & Wealth Management's PPBT Position: Q4 2021 in Review

Walled Lake Planning & Wealth Management sold out of Purple Biotech (PPBT) in Q4 2021, closing a stake of 1 share.

Walled Lake Planning & Wealth Management first reported a position in PPBT in Q2 2020 and held it in 6 quarters. The position peaked at $1K in Q2 2020. 10 funds tracked by Wall St. Rank hold PPBT as of Q4 2021.

  • Walled Lake Planning & Wealth Management reported no remaining Purple Biotech position as of Q4 2021 after selling out during the quarter.
  • Walled Lake Planning & Wealth Management sold 1 Purple Biotech share in Q4 2021.
  • Walled Lake Planning & Wealth Management first reported a position in Purple Biotech in Q2 2020 and held it in 6 quarters.
  • Walled Lake Planning & Wealth Management's Purple Biotech position peaked at $1K in Q2 2020.
  • 10 funds tracked by Wall St. Rank held Purple Biotech as of Q4 2021.

Based on Walled Lake Planning & Wealth Management's 13F filing for Q4 2021, filed 10 Feb 2022.